Human ABCB1 confers cells resistance to cytotoxic guanidine alkaloids from Pterogyne nitens

Abstract

Multidrug resistance (MDR) caused by human ABCB1 (P-glycoprotein/MDR1) is one of the major obstacles in chemotherapy. To understand the mechanism of MDR by ABCB1 and circumvent the MDR, in the present study, we established human ABCB1-expressing cells (Flp-In-293/ABCB1 cells) and examined the cytotoxic effects of four guanidine alkaloids from Pterogyne nitens (galegine, nitensidine A, pterogynidine and pterogynine) using Flp-In-293/Mock and Flp-In-293/ABCB1 cells. The activity of ABCB1 in Flp-In-293/ABCB1 cells were confirmed by typical substrates for ABCB1 (taxol and vinblastine) in MTT assay. Flp-In-293/ABCB1 cells were also resistant to the four guanidine alkaloids as well as taxol and vinblastine compared to Flp-In-293/Mock cells although the four guanidine alkaloids exhibited cytotoxicity against the two Flp-In-293 cells. Furthermore, the four guanidine alkaloids were also found to stimulate the ATPase activity of ABCB1 in ATPase assays. These results suggest that ABCB1 can confer the resistance to the cytotoxic guanidine alkaloids by transporting them.

Keywords

ABCB1 P-glycoprotein ATP-binding cassette (ABC) transporter guanidine alkaloids

Get full access to this article

View all access options for this article.

References

[1] Juliano

R.L.

and Ling

, A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants, Biochimica et Biophysica Acta 455 (1976), 152–162.

[2] Ueda

Cornwell

M.M.

Gottesman

M.M.

Pastan

Roninson

I.B.

Riordan

J.R.

et al., The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein, Biochemical and Biophysical Research Communications 141 (1986), 956–962.

[3] Chen

C.J.

Chin

J.E.

Ueda

Clark

D.P.

Pastan

Gottesman

M.M.

et al., Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells, Cell 47 (1986), 381–389.

[4] de Jong

F.A.

de Jonge

M.J.

Verweij

and Mathijssen

R.H.

, Role of pharmacogenetics in irinotecan therapy, Cancer Letters 234 (2006), 90–106.

[5] Ishikawa

, Multidrug resistance: Genomics of ABC transporters, in: Nature Encyclopedia of the Human Genome, Nature Publishing Group Cooper

D.N.

, ed., 2003, pp. 154–160.

[6] Gribar

J.J.

Ramachandra

Hrycyna

C.A.

Dey

and Ambudkar

S.V.

, Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system, J. Membr. Biol. 173 (2000), 203–214.

[7] Ling

, Multidrug resistance: Molecular mechanisms and clinical relevance, Cancer Chemotherapy and Pharmacology 40 Suppl. (1997), S3–S8.

[8] Schinkel

A.H.

Smit

J.J.

van Tellingen

Beijnen

J.H.

Wagenaar

te Riele

H.P.

et al., Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs, Cell 77 (1994), 491–502.

[9] Regasini

L.O.

Castro-Gamboa

Silva

D.H.

Furlan

Barreiro

E.J.

and Bolzani Vda

, Cytotoxic guanidine alkaloids from Pterogyne nitens , J. Nat. Prod. 72 (2009), 473–476.

10.

[10] Duarte

R.A.

Mello

E.R.

Araki

Bolzani Vda

Siqueira e Silva

D.H.

Soares

C.P.

et al., Alkaloids extracted from Pterogyne nitens induce apoptosis in malignant breast cell line, Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 31 (2010), 513–522.

11.

[11] Wakabayashi

Nakagawa

Adachi

Kii

Kobatake

Ishikawa

et al., Identification of cysteine residues critically involved in homodimer formation and protein expression of human ATP-binding cassette transporter ABCG2: A new approach using the flp recombinase system, J. Exp. Ther. Oncol. 5 (2006), 205–222.

12.

[12] Tamura

Wakabayashi

Onishi

Nakagawa

Tsuji

Ishikawa

et al., Genetic polymorphisms of human ABC transporter ABCG2: Development of the standard method for functional validation of SNPs by using the Flp recombinase system, J. Exp. Ther. Oncol. 6 (2006), 1–11.

13.

[13] O’Gorman

Fox

D.T.

and Wahl

G.M.

, Recombinase-mediated gene activation and site-specific integration in mammalian cells, Science 251 (1991), 1351–1355.

14.

[14] Sauer

, Site-specific recombination: Developments and applications, Curr. Opin. Biotechnol. 5 (1994), 521–527.

15.

[15] Wirth

and Hauser

, Flp-mediated integration of expression cassettes into FRT-tagged chromosomal loci in mammalian cells, Methods in Molecular Biology 267 (2004), 467–476.

16.

[16] Sakurai

Onishi

Hirano

Seigneuret

Obanayama

Ishikawa

et al., Quantitative structure–activity relationship analysis and molecular dynamics simulation to functionally validate nonsynonymous polymorphisms of human ABC transporter ABCB1 (P-glycoprotein/MDR1), Biochemistry 46 (2007), 7678–7693.

17.

[17] Schinkel

A.H.

Wagenaar

Mol

C.A.

and van Deemter

, P-glycoprotein in the blood–brain barrier of mice influences the brain penetration and pharmacological activity of many drugs, The Journal of Clinical Investigation 97 (1996), 2517–2524.